It was reported that HIF-1α stability was maintained, and HIF-1 was activated in VHL-deficient cells (52).Hsp90 inhibitors promoted effective ubiquitination and proteasome-mediated degradation of HIF-1α in RCC under normoxic and hypoxic conditions (53). The gene discussed is HIF1A; the disease is renal cell carcinoma.